×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DXCM – dexcom, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DXCM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/16
08:37 pm
dxcm
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now [Yahoo! Finance]
Low
Report
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now [Yahoo! Finance]
3/16
12:29 pm
dxcm
Is Dexcom (DXCM) Fairly Priced After Recent Share Price Pressure? [Yahoo! Finance]
Low
Report
Is Dexcom (DXCM) Fairly Priced After Recent Share Price Pressure? [Yahoo! Finance]
3/16
12:03 pm
dxcm
Europe Blood Glucose Monitoring Market Report 2026-2031: Revenues to Exceed USD 9 Billion by 2031 [Yahoo! Finance]
Low
Report
Europe Blood Glucose Monitoring Market Report 2026-2031: Revenues to Exceed USD 9 Billion by 2031 [Yahoo! Finance]
3/13
04:58 pm
dxcm
We tried continuous glucose monitors from Lingo and Stelo for 2 weeks. Here's which one is better [CNN]
Medium
Report
We tried continuous glucose monitors from Lingo and Stelo for 2 weeks. Here's which one is better [CNN]
3/11
11:53 am
dxcm
DexCom (DXCM) had its price target raised by Citigroup Inc. from $77.00 to $84.00. They now have a "buy" rating on the stock.
Low
Report
DexCom (DXCM) had its price target raised by Citigroup Inc. from $77.00 to $84.00. They now have a "buy" rating on the stock.
3/11
02:17 am
dxcm
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 [Yahoo! Finance]
Low
Report
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 [Yahoo! Finance]
3/11
02:00 am
dxcm
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
Low
Report
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
3/9
08:03 am
dxcm
DexCom (DXCM) had its "buy" rating reaffirmed by BTIG Research. They now have a $85.00 price target on the stock.
Low
Report
DexCom (DXCM) had its "buy" rating reaffirmed by BTIG Research. They now have a $85.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/16
04:02 pm
dxcm
Form 144 DEXCOM INC Filed by: Brown Michael Jon
Low
Report
Form 144 DEXCOM INC Filed by: Brown Michael Jon
3/10
04:02 pm
dxcm
Form 4 DEXCOM INC For: Mar 08 Filed by: Sylvain Jereme M
Low
Report
Form 4 DEXCOM INC For: Mar 08 Filed by: Sylvain Jereme M
3/10
04:02 pm
dxcm
Form 4 DEXCOM INC For: Mar 08 Filed by: Leach Jacob Steven
Low
Report
Form 4 DEXCOM INC For: Mar 08 Filed by: Leach Jacob Steven
3/10
04:02 pm
dxcm
Form 4 DEXCOM INC For: Mar 08 Filed by: Coleman Jon
Low
Report
Form 4 DEXCOM INC For: Mar 08 Filed by: Coleman Jon
3/10
04:02 pm
dxcm
Form 4 DEXCOM INC For: Mar 08 Filed by: SAYER KEVIN R
Low
Report
Form 4 DEXCOM INC For: Mar 08 Filed by: SAYER KEVIN R
3/10
04:02 pm
dxcm
Form 4 DEXCOM INC For: Mar 08 Filed by: Brown Michael Jon
Low
Report
Form 4 DEXCOM INC For: Mar 08 Filed by: Brown Michael Jon
3/10
04:02 pm
dxcm
Form 4 DEXCOM INC For: Mar 08 Filed by: Stern Sadie
Low
Report
Form 4 DEXCOM INC For: Mar 08 Filed by: Stern Sadie
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/6
Q3/2019 9/30/2019 EPS 0.650 ZacksConsensus 0.200 ActVsEst 0.450 - Beat
27.2%
2/13 Q4/2019 12/31/2019 EPS 1.150 ZacksConsensus 0.750 ActVsEst 0.400 - Beat 12.0%
4/28 Q1/2020 3/31/2020 EPS 0.440 ZacksConsensus 0.100 ActVsEst 0.340 - Beat 10.3%
4/8 Form 4 DEXCOM INC For: Apr 07 Filed by: SAYER KEVIN R 7.9%
4/15 Top-Ranked Medical Duo Breaks Out — But Only One Holds Onto Its Gain [Investor's Business Daily] 4.9%
4/1 Form 4 DEXCOM INC For: Mar 30 Filed by: Selvaraj Shelly Ramasamy 4.9%
6/11 Form 4 DEXCOM INC For: Jun 10 Filed by: SAYER KEVIN R 4.9%
3/9 Form 4 DEXCOM INC For: Mar 05 Filed by: Pacelli Steven Robert 4.8%
2/14 IBD 50 Watchlist Of Growth Stocks Adds Nvidia, Tradeweb, Veeva, Wex [Investor's Business Daily] 4.6%
3/25 Form 4 DEXCOM INC For: Mar 13 Filed by: DOUBLEDAY RICHARD 4.5%
2/13 Q4/2019 12/31/2019 EPS 1.150 ZacksConsensus 0.750 ActVsEst 0.400 - Beat 12.0%
4/28 Q1/2020 3/31/2020 EPS 0.440 ZacksConsensus 0.100 ActVsEst 0.340 - Beat 10.3%
4/8 Form 4 DEXCOM INC For: Apr 07 Filed by: SAYER KEVIN R 7.9%
4/15 Top-Ranked Medical Duo Breaks Out — But Only One Holds Onto Its Gain [Investor's Business Daily] 4.9%
4/1 Form 4 DEXCOM INC For: Mar 30 Filed by: Selvaraj Shelly Ramasamy 4.9%
6/11 Form 4 DEXCOM INC For: Jun 10 Filed by: SAYER KEVIN R 4.9%
3/9 Form 4 DEXCOM INC For: Mar 05 Filed by: Pacelli Steven Robert 4.8%
2/14 IBD 50 Watchlist Of Growth Stocks Adds Nvidia, Tradeweb, Veeva, Wex [Investor's Business Daily] 4.6%
3/25 Form 4 DEXCOM INC For: Mar 13 Filed by: DOUBLEDAY RICHARD 4.5%
TOP News Decliners
3/14
Coronavirus Bear Market: All Stocks Are Under Quarantine, But Keep Vertex, Biogen, Dexcom, Eli Lilly, Masimo Under Observation [Investor's Business Daily]
-15.6%
3/10 Form 8-K DEXCOM INC For: Mar 10 -9.6%
9/7 DexCom, Inc. (NASDAQ: DXCM) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -9.4%
8/1 DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Robert W. Baird from $180.00 to $186.00. They now have an "outperform" rating on the stock. -7.5%
4/27 DexCom Q1 2020 Earnings Preview [Seeking Alpha] -7.0%
10/8 Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM -5.9%
3/19 Hedge Funds Have Never Been This Bullish On DexCom, Inc. (DXCM) [Yahoo! Finance News] -5.4%
7/2 Dexcom Schedules Second Quarter 2019 Earnings Release and Conference Call for July 31, 2019 at 4:30 p.m. Eastern Time -4.6%
9/5 Form 4 DEXCOM INC For: Sep 03 Filed by: Balo Andrew K -4.4%
2/20 Form 4 DEXCOM INC For: Feb 18 Filed by: Collins Richard Alexander -4.1%
3/10 Form 8-K DEXCOM INC For: Mar 10 -9.6%
9/7 DexCom, Inc. (NASDAQ: DXCM) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -9.4%
8/1 DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Robert W. Baird from $180.00 to $186.00. They now have an "outperform" rating on the stock. -7.5%
4/27 DexCom Q1 2020 Earnings Preview [Seeking Alpha] -7.0%
10/8 Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM -5.9%
3/19 Hedge Funds Have Never Been This Bullish On DexCom, Inc. (DXCM) [Yahoo! Finance News] -5.4%
7/2 Dexcom Schedules Second Quarter 2019 Earnings Release and Conference Call for July 31, 2019 at 4:30 p.m. Eastern Time -4.6%
9/5 Form 4 DEXCOM INC For: Sep 03 Filed by: Balo Andrew K -4.4%
2/20 Form 4 DEXCOM INC For: Feb 18 Filed by: Collins Richard Alexander -4.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: